Tempus AI Inc at JPMorgan Healthcare Conference Transcript
All right, great. Welcome, everybody. I'm Casey Woodring from the Life Science Tools and Diagnostics Team here at JPMorgan. Welcome to our conference.
Pleased to be joined by Tempus AI's CEO, Eric Lefkofsky. We'll go through the corporate presentation, then leave time for the Q&A afterwards.
Eric, all yours.
Thank you. Welcome. I don't know if there's seats up here, there's people in the back, but all means, feel free to walk up.
So I'll try to give you a little context of what we've been building at Tempus and a little bit about where we're at now.
So 10 years ago, we started Tempus to solve a single problem. Could AI-enabled diagnostics unlock precision medicine? Essentially, could we use diagnostics as a vehicle to make precision medicine as opposed to targeted medicine a reality.
In order to do so, you really need two things. You need access to vast amounts of proprietary data to train
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
